Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.
Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Never miss any important news. Subscribe to our newsletter.
Never miss any important news. Subscribe to our newsletter.
Recent News
At the Brooklyn Academy, Musical Journeys Through Minefields
November 26, 2024
Florida Woman Who Fatally Shot Black Neighbor Gets 25 Years in Prison
November 26, 2024
Crony Capitalism Is Coming to America
November 26, 2024
Best Thanksgiving Episodes to Stream: ‘Friends,’ ‘Succession’ and More
November 26, 2024
End of Trump Cases Leaves Limits on Presidential Criminality Unclear
November 26, 2024
Kohl’s Picks C.E.O. of Michaels to Help It Turn Around
November 26, 2024